JP Nadda declares India free from infective trachoma

New Delhi, December 9: Health Minister J P Nadda on Friday declared that India is now free from infective trachoma and termed this as a momentous achievement. Notably, Trachoma is a chronic infective disease of the eye and is the leading cause of infective blindness globally.

 

Health Minister J P Nadda released the National Trachoma Survey Report (2014-17) in New Delhi and declared that India is now free from ‘infective trachoma’. Minister Nadda stated that the survey findings indicate that the active trachoma infection has been eliminated among children in all the survey districts with an overall prevalence of only 0.7%.

“This is much below the elimination criteria of infective trachoma as defined by the WHO- active trachoma is considered eliminated if the prevalence of active infection among children below 10 years is less than 5%,” he added.

The Health Minister also stated that the Survey results indicate that active trachoma is no longer a public health problem in India. “We have met the goal of trachoma elimination as specified by the WHO under its GET2020 program,” he said.

Minister Nadda also noted that this has been possible due to decades of inter-sectoral interventions and efforts that included a provision of antibiotic eye drops, personal hygiene, availability of safe water, improved environmental sanitation, availability of surgical facilities for chronic trachoma, and a general improvement in the socio-economic status in the country.

On the occasion, Minister Nadda also emphasized the need for constant surveillance by the states to report any fresh cases of trachoma and trachoma sequelae (TT cases) and to treat them promptly to finally be completely free of trachoma.

At the release of the Survey Report, Minister Nadda further noted that it is our aim to eliminate trachomatous trichiasis from the country. States which still report cases of active trachoma need to develop a strategy for community-based case finding of patients of trachomatous trichiasis (TT). “These cases must be provided free entropion surgery/ treatment in local hospitals,” he added.

The Union Minister also said that a careful record of each case identified and its management status must be maintained as per the WHO Guidelines. Also, adequate surveillance of the disease must be done all over the country in order to certify India as trachoma-free (eliminated). Monthly data on indicators of trachoma surveillance as per WHO guidelines must be regularly sent to the NPCB, he urged the states.

Trachoma is a chronic infective disease of the eye and is the leading cause of infective blindness globally. Trachoma is a disease of poor environmental and personal hygiene and inadequate access to water and sanitation. It affects the conjunctiva under the eyelids. Repeated infections cause scarring leading to in-turning of the eyelashes and eyelids. This further causes damage to the cornea and blindness.

Trachoma is found affecting the population in certain pockets of the States of North India like Gujarat, Rajasthan, Punjab, Haryana, Uttar Pradesh and the Nicobar Islands. Trachoma infection of the eyes was the most important cause of blindness in India in the 1950s and over 50% population was affected in Gujarat, Rajasthan, Punjab, and Uttar Pradesh. It was the most important cause of corneal blindness in India, affecting young children.

The National Trachoma Prevalence Surveys and the Trachoma Rapid Assessment Surveys were conducted by Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi in collaboration with National Program for Control of Blindness & Visual Impairment, Union Ministry of Health and Family Welfare from 2014 to 2017.

This was conducted in 27 high-risk districts across 23 states and union territories. Trachoma Prevalence Surveys were done in 10 districts selected from the previously hyper-endemic states. Under the survey, 19662 children in 1-9 year age group were examined by trained ophthalmologists. As many as 44135 persons were examined among the 15yr+ age group. The Trachoma Rapid Assessment Surveys (TRA) was done in 17 other districts from other parts of the country in places where trachoma cases have been reported, which were not previously hyper-endemic.